JP2005528921A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528921A5 JP2005528921A5 JP2004511543A JP2004511543A JP2005528921A5 JP 2005528921 A5 JP2005528921 A5 JP 2005528921A5 JP 2004511543 A JP2004511543 A JP 2004511543A JP 2004511543 A JP2004511543 A JP 2004511543A JP 2005528921 A5 JP2005528921 A5 JP 2005528921A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- patient
- drug
- level
- fractalkine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38769902P | 2002-06-10 | 2002-06-10 | |
| PCT/US2003/018570 WO2003104484A1 (en) | 2002-06-10 | 2003-06-10 | Methods of treating and diagnosing diabetes with cx3cr1 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528921A JP2005528921A (ja) | 2005-09-29 |
| JP2005528921A5 true JP2005528921A5 (cg-RX-API-DMAC7.html) | 2006-08-10 |
Family
ID=29736354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004511543A Withdrawn JP2005528921A (ja) | 2002-06-10 | 2003-06-10 | Cx3cr1修飾物質を用いる糖尿病の治療および診断の方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060160076A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1511850A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005528921A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003243532A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2487438A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003104484A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005103684A2 (en) * | 2004-04-20 | 2005-11-03 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with cx3c chemokine receptor 1 (cx3cr1) |
| EP2023144A1 (en) * | 2007-08-01 | 2009-02-11 | Sanofi-Aventis | Novel AS160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics |
| US20090136465A1 (en) | 2007-09-28 | 2009-05-28 | Intrexon Corporation | Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof |
| CN108610421B (zh) | 2012-02-27 | 2022-08-19 | 阿布林克斯有限公司 | Cx3cr1结合多肽 |
| JP2015514685A (ja) | 2012-03-01 | 2015-05-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 糖尿病および循環器病の診断および治療のための新たな標的 |
| US9637542B2 (en) * | 2013-08-21 | 2017-05-02 | Boehringer Ingelheim International Gmbh | CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease |
| CN103656639B (zh) * | 2013-12-18 | 2015-02-18 | 南方医科大学南方医院 | 不规则趋化因子的中和抗体用于制备消除糖尿病心肾功能损害不良代谢记忆的药物的用途 |
| CN109891237B (zh) | 2016-10-24 | 2022-08-23 | 诺和诺德股份有限公司 | 胰岛素制剂的生物测定法 |
| WO2025264930A1 (en) * | 2024-06-19 | 2025-12-26 | The Trustees Of The University Of Pennsylvania | Compositions and methods for immune cell trafficking modulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107475A (en) * | 1992-11-17 | 2000-08-22 | Icos Corporation | Seven transmembrane receptors |
| ES2118372T3 (es) * | 1992-11-17 | 1998-09-16 | Icos Corp | Nuevos receptores siete transmembrana v28. |
| US6699677B1 (en) * | 1999-12-20 | 2004-03-02 | Chemocentryx, Inc. | Tethered ligands and methods of use |
-
2003
- 2003-06-10 AU AU2003243532A patent/AU2003243532A1/en not_active Abandoned
- 2003-06-10 WO PCT/US2003/018570 patent/WO2003104484A1/en not_active Ceased
- 2003-06-10 EP EP03757495A patent/EP1511850A4/en not_active Withdrawn
- 2003-06-10 JP JP2004511543A patent/JP2005528921A/ja not_active Withdrawn
- 2003-06-10 CA CA002487438A patent/CA2487438A1/en not_active Abandoned
- 2003-06-10 US US10/516,032 patent/US20060160076A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mannucci et al. | Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects | |
| Andreelli et al. | Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients | |
| Straub et al. | Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression | |
| JP2010031018A5 (cg-RX-API-DMAC7.html) | ||
| Papadopoulos et al. | Adiponectin and resistin plasma levels in healthy individuals with prehypertension | |
| Lucarini et al. | Involvement of vascular endothelial growth factor, CD44 and CD133 in periodontal disease and diabetes: an immunohistochemical study | |
| CN111925420B (zh) | 一种多肽作为嗅觉受体Olfr109激动剂配体的应用 | |
| Chidambaram et al. | Replication of genome-wide association signals in Asian Indians with early-onset type 2 diabetes | |
| CN105385774A (zh) | Tmf1作为帕金森症诊断标志物的用途 | |
| CN112795645B (zh) | 一种用于指导人高血糖用药的试剂盒 | |
| CN111925419B (zh) | 一种多肽作为嗅觉受体Olfr109拮抗剂配体的应用 | |
| JP2009516155A5 (cg-RX-API-DMAC7.html) | ||
| JP2005529603A5 (cg-RX-API-DMAC7.html) | ||
| JP2005528080A5 (cg-RX-API-DMAC7.html) | ||
| EP3678686A1 (en) | Modified fibroblast growth factor 21 (fgf-21) for use in methods for treating nonalcoholic steatohepatitis (nash) | |
| JP2007500005A5 (cg-RX-API-DMAC7.html) | ||
| KR102935795B1 (ko) | 유전자 마커를 이용한 설폰요소제 의존성 예측용 조성물 및 그 예측 방법 | |
| JP2006500002A5 (cg-RX-API-DMAC7.html) | ||
| Hayashino et al. | Normal fasting plasma glucose levels and type 2 diabetes: the high-risk and population strategy for occupational health promotion (HIPOP-CHP) study | |
| CN1157406C (zh) | 新的atp敏感性钾离子通道蛋白和其基因 | |
| Jacobs et al. | Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys (B28), Pro (B29) human insulin analogue (insulin lispro) in healthy male volunteers | |
| JP2005522229A5 (cg-RX-API-DMAC7.html) | ||
| Davidson et al. | Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus | |
| Matuleviciene Anängen | Type 1 diabetes in adults: modern treatment and risk of major coronary events | |
| JP2011509080A5 (cg-RX-API-DMAC7.html) |